Suppr超能文献

新型生物活性复合淀粉/生物活性玻璃微粒的合成与评价

Synthesis and evaluation of novel bioactive composite starch/bioactive glass microparticles.

作者信息

Silva G A, Costa F J, Coutinho O P, Radin S, Ducheyne P, Reis R L

机构信息

3B's Research Group, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

出版信息

J Biomed Mater Res A. 2004 Sep 1;70(3):442-9. doi: 10.1002/jbm.a.30099.

Abstract

The aim of the development of composite materials is to combine the most desired properties of two or more materials. In this work, the biodegradable character, good controlled-release properties, and natural origin of starch-based biomaterials are combined with the bioactive and bone-bonding properties of bioactive glass (BG). Novel, bioactive composite starch-BG microparticles were synthesized starting from a blend of starch and polylactic acid (50%/50% wt) with BG 45S5 powder using a simple emulsion method. Morphological and chemical characterization showed that these particles exhibited a spherical morphology with sizes up to 350 microm and that BG 45S5 was incorporated successfully into the composite particles. Upon immersion in a solution simulating body fluids, for periods up to 3 weeks, their bioactive nature was confirmed, as a calcium-phosphate layer resembling biological apatite was formed onto their surface. The short-term cytotoxicity of these materials was also tested by placing 24-h leachables of the materials extracted in culture medium in contact with a fibroblastic cell line (L929) up to 72 h. At this time period, two biochemical tests--MTT and total protein quantification--were performed. The results showed that these materials are not cytotoxic. These results constitute the basis of future encapsulation studies using bone-acting therapeutic agents such as bone morphogenetic proteins or other bone-relevant factors. The particles developed here may be very useful for applications in which controlled release, degradability, and bone-bonding ability are the main requirements.

摘要

复合材料研发的目的是将两种或更多材料最理想的特性结合起来。在这项工作中,淀粉基生物材料的生物可降解特性、良好的控释性能和天然来源与生物活性玻璃(BG)的生物活性及骨结合性能相结合。采用简单的乳液法,以淀粉和聚乳酸(50%/50%重量比)的混合物与BG 45S5粉末为原料,合成了新型生物活性复合淀粉 - BG微粒。形态学和化学表征表明,这些微粒呈现球形形态,尺寸可达350微米,且BG 45S5成功地掺入了复合微粒中。将其浸泡在模拟体液的溶液中长达3周,其生物活性得到证实,因为在其表面形成了一层类似生物磷灰石的磷酸钙层。还通过将在培养基中提取的材料的24小时浸出物与成纤维细胞系(L929)接触长达72小时,测试了这些材料的短期细胞毒性。在此时间段内,进行了两项生化测试——MTT和总蛋白定量。结果表明这些材料没有细胞毒性。这些结果构成了未来使用骨作用治疗剂(如骨形态发生蛋白或其他与骨相关的因子)进行包封研究的基础。这里研发的微粒对于那些以控释、可降解性和骨结合能力为主要要求的应用可能非常有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验